HCP2202

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Healthy

Phase 1

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers

CompletedNCT05548387

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2022-09-02End: 2022-11-10Updated: 2023-09-22

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

CompletedNCT05548543

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2022-10-17End: 2022-12-22Updated: 2023-09-22